{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:58:48Z","timestamp":1790834328082,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.humimm.2013.11.014","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T18:01:37Z","timestamp":1385056897000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia"],"prefix":"10.1016","volume":"75","author":[{"given":"Yuan-xin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-li","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2013.11.014_b0005","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-08-3010","article-title":"Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia","volume":"15","author":"Szczepanski","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humimm.2013.11.014_b0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04011.x","article-title":"Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukemia","volume":"158","author":"Wu","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0015","first-page":"18","article-title":"Characteristics of T-cell immunity in patients with acute leukemia","volume":"78","author":"Parovichnikova","year":"2006","journal-title":"Ter Arkh"},{"key":"10.1016\/j.humimm.2013.11.014_b0020","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.4049\/jimmunol.167.10.6021","article-title":"Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways","volume":"167","author":"Buggins","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0025","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2013.11.014_b0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/10428190290026385","article-title":"Th1\/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin\u2019s lymphoma (NHL)","volume":"43","author":"Jones","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humimm.2013.11.014_b0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1751-553X.2008.01090.x","article-title":"Clinical significance of Th1\/Th2 ratio in patients with myelodysplastic syndrome","volume":"31","author":"Hamdi","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.humimm.2013.11.014_b0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2013.11.014_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jcb.10054","article-title":"Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis","volume":"38","author":"Schwarzenberger","year":"2002","journal-title":"J Cell Biochem Suppl"},{"key":"10.1016\/j.humimm.2013.11.014_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.2010.02432.x","article-title":"Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation","volume":"72","author":"J\u00e4ger","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0055","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2013.11.014_b0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10875-011-9540-8","article-title":"Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis","volume":"31","author":"Zhang","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.humimm.2012.04.015","article-title":"Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia","volume":"73","author":"Hu","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cytogfr.2010.10.007","article-title":"Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease","volume":"21","author":"Ouyang","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.humimm.2013.11.014_b0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2013.11.014_b0080","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humimm.2013.11.014_b0085","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.4049\/jimmunol.173.11.6745","article-title":"Antiapoptotic microenvironment of acute myeloid leukemia","volume":"173","author":"Milojkovic","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0090","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/ni1208-1323","article-title":"Alternative lifestyles of T cells","volume":"9","author":"Tato","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1684\/ecn.2012.0322","article-title":"The angioregulatory cytokine network in human acute myeloid leukemia \u2013 from leukemogenesis via remission induction to stem cell transplantation","volume":"23","author":"Reikvam","year":"2012","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.humimm.2013.11.014_b0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbmt.2011.10.007","article-title":"The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of post-transplantation complications","volume":"18","author":"Reikvam","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2013.11.014_b0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.2001.01692.x","article-title":"Acute myeloid leukemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function\u2013implications for the adoptive immunotherapy of leukemia","volume":"126","author":"Orleans-Lindsay","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.2010.00951.x","article-title":"Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors","volume":"238","author":"Zhu","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humimm.2013.11.014_b0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0120","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.4049\/jimmunol.1100315","article-title":"Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance","volume":"186","author":"Chaturvedi","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0125","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-0609.2005.00537.x","article-title":"Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients","volume":"75","author":"Wang","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humimm.2013.11.014_b0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3892\/ol.2012.614","article-title":"Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-beta in acute myeloid leukemia","volume":"3","author":"Wu","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.humimm.2013.11.014_b0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.humimm.2013.11.014_b0145","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.humimm.2013.11.014_b0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jss.2012.07.055","article-title":"Prevalence and clinical relevance of Th17 cells in patients with gastric cancer","volume":"178","author":"Yamada","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.humimm.2013.11.014_b0155","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2741\/4052","article-title":"Th17 related cytokines in acute myeloid leukemia","volume":"17","author":"Li","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.humimm.2013.11.014_b0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaci.2008.12.017","article-title":"Differentiation and functional analysis of human TH17 cells","volume":"123","author":"Burgler","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2013.11.014_b0170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2013.11.014_b0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2172-11-38","article-title":"Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17, and TREG cells","volume":"11","author":"Ersvaer","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajh.23116","article-title":"Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment","volume":"87","author":"Fredly","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2013.11.014_b0185","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood.V74.6.2081.2081","article-title":"Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation","volume":"74","author":"van der Schoot","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2013.11.014_b0190","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4049\/jimmunol.150.6.2418","article-title":"Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines","volume":"150","author":"Testa","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2013.11.014_b0195","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2013.11.014_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.humimm.2013.11.014_b0205","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.24486","article-title":"Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3","volume":"54","author":"Jiang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2013.11.014_b0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2012.07.002","article-title":"Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia","volume":"50","author":"Gangemi","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.humimm.2013.11.014_b0215","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-07-4401","article-title":"Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913005776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913005776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T08:42:55Z","timestamp":1688805775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885913005776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0198885913005776"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2013.11.014","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2013.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}